What is Pharmatech Associates?
Pharmatech Associates, Inc. is a specialized consultancy focused on providing expert Chemistry, Manufacturing, and Controls (CMC), quality, and regulatory support for the development of biologics, cell and gene therapies, combination products, and small molecules. The company's comprehensive service portfolio encompasses regulatory affairs, product development strategy, continuous manufacturing implementation, and facilities design. By offering tailored solutions, Pharmatech Associates aims to guide pharmaceutical and biotechnology clients through the intricate landscape of drug development, facilitating timely market approvals, particularly within the United States. Their core mission is to enhance compliance, optimize development processes, and support successful market entry for innovative therapies.
How much funding has Pharmatech Associates raised?
Pharmatech Associates has raised a total of $1.1M across 2 funding rounds:
Debt
$350K
Debt
$765K
Debt (2020): $350K with participation from PPP
Debt (2021): $765K led by PPP
Key Investors in Pharmatech Associates
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Pharmatech Associates?
The recent major strategic investment indicates Pharmatech Associates is likely in a growth or scaling phase, potentially leveraging this capital to expand its service offerings, enhance its technological capabilities, or broaden its market reach. The company's focus on biologics and advanced therapies suggests a strategic alignment with emerging trends in the pharmaceutical industry. Future developments may involve deeper integration of its regulatory and manufacturing support services to offer end-to-end solutions for clients navigating the complex path from discovery to commercialization.
See full Pharmatech Associates company page
